Sign Out
Pregnancy: Pregnancy should be excluded before Diphereline P.R. is prescribed.
Triptorelin should not be used during pregnancy since concurrent use of GnRH agonists is associated with a theoretical risk of abortion or foetal abnormality. Prior to treatment, potentially fertile women should be examined carefully to exclude pregnancy. Non-hormonal methods of contraception should be employed during therapy until menses resume.
Breast-feeding: Triptorelin should not be used during breastfeeding.
Fertility: There is no clinical evidence to suggest a causal connection between triptorelin and any subsequent abnormalities of oocyte development or pregnancy or outcome.
